Ceramedix Holding, LLC

Ceramedix

New York, United States · Founded 2018 · $3.0M raised

Headquarters
New York, New York
Employees
1–10
Founded
2018
Business Model
B2B
Total Funding
$3.0M
Last Round
$3.0M GrantAug 2023
Rounds
1

About

Ceramedix is a preclinical-stage biotherapeutics company developing a novel class of pharmacologic drugs targeting disease mechanisms involving the microvasculature. The company's lead candidate is an anti-ceramide antibody designed to disrupt cell death signaling, with initial applications in radiation exposure mitigation and ophthalmic diseases including diabetic retinopathy. Ceramedix has received multiple NIH SBIR grants including a Phase 2B award to support IND submission.

Summary

Ceramedix Holding, LLC is a Biotech company based in New York, United States, founded in 2018. It has raised $3.0M in total across 1 round, most recently a $3.0M Grant round in Aug 2023. Investors include National Institute of Allergy and Infectious Diseases.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantAug 2023
$3.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Ceramedix Holding, LLC on Indexed.vc
<a href="https://indexed.vc/companies/ceramedix-holding-llc"><img src="https://indexed.vc/api/badge/company/ceramedix-holding-llc" alt="Ceramedix Holding, LLC on Indexed.vc" width="260" height="76" /></a>